Alcresta’s RELiZORB shows BMI and weight gains in pediatric tube-fed patients
See how RELiZORB improved weight and BMI z-scores in tube-fed children aged 1–5 in new real-world data. Explore what this means for pediatric care today.
Pharma & Biotech